PTC Therapeutics
PTCT
PTCT
238 hedge funds and large institutions have $3.51B invested in PTC Therapeutics in 2024 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 78 increasing their positions, 76 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.69% less ownership
Funds ownership: 102.46% → 100.76% (-1.7%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
62% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $28.2M
Holders
238
Holding in Top 10
3
Calls
$10.6M
Puts
$28.2M
Top Buyers
| 1 | +$148M | |
| 2 | +$47M | |
| 3 | +$40.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$39.2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$20.6M |
Top Sellers
| 1 | -$140M | |
| 2 | -$38.7M | |
| 3 | -$29.8M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$19.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$13.5M |